Meridian Bioscience Q1 Revenues Fall 2 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Meridian Bioscience today reported that its first quarter revenues fell 2 percent year over year.

The company said revenues decreased to $47.2 million for the three months ended Dec. 31, 2015, from $48.0 million a year ago, missing analysts' consensus estimate of $48.6 million in revenues for the quarter.

However, the firm's net earnings for the quarter rose 13 percent to $8.9 million, or $.21 per share, compared to $7.9 million, or $.19 per share, for Q1 2015, and matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.